Your browser doesn't support javascript.
loading
Thoracic Visceral Adipose Tissue Area and Pulmonary Hypertension in Lung Transplant Candidates. The Lung Transplant Body Composition Study.
Al-Naamani, Nadine; Pan, Hao-Min; Anderson, Michaela R; Torigian, Drew A; Tong, Yubing; Oyster, Michelle; Porteous, Mary K; Palmer, Scott; Arcasoy, Selim M; Diamond, Joshua M; Udupa, Jayaram K; Christie, Jason D; Lederer, David J; Kawut, Steven M.
Afiliación
  • Al-Naamani N; Department of Medicine and.
  • Pan HM; Department of Medicine and.
  • Anderson MR; Department of Medicine, Columbia University Medical Center, New York, New York.
  • Torigian DA; Department of Radiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Tong Y; Department of Radiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Oyster M; Department of Medicine and.
  • Porteous MK; Department of Medicine and.
  • Palmer S; Department of Medicine, Duke University, Durham, North Carolina; and.
  • Arcasoy SM; Department of Medicine, Columbia University Medical Center, New York, New York.
  • Diamond JM; Department of Medicine and.
  • Udupa JK; Department of Radiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Christie JD; Department of Medicine and.
  • Lederer DJ; Department of Medicine, Columbia University Medical Center, New York, New York.
  • Kawut SM; Regeneron Pharmaceuticals Inc., Tarrytown, New York.
Ann Am Thorac Soc ; 17(11): 1393-1400, 2020 11.
Article en En | MEDLINE | ID: mdl-32530703
ABSTRACT
Rationale Obesity is associated with an increased risk of pulmonary hypertension (PH); however, regional adipose tissue deposition is heterogeneous with distinct cardiovascular phenotypes.

Objectives:

To determine the association of body mass index (BMI) and thoracic visceral and subcutaneous adipose tissue areas (VAT and SAT, respectively) with PH in patients with advanced lung disease referred for lung transplantation.

Methods:

We studied patients undergoing evaluation for lung transplantation at three centers from the Lung Transplant Body Composition Study. PH was defined as mean pulmonary artery pressure >20 mm Hg and pulmonary vascular resistance ≥3 Wood units. VAT and SAT were measured on chest computed tomography and normalized to height squared.

Results:

One hundred thirty-seven (34%) of 399 patients included in our study had PH. Doubling of thoracic VAT was associated with significantly lower pulmonary vascular resistance (ß, -0.24; 95% confidence interval [95% CI], -0.46 to -0.02; P = 0.04), higher pulmonary arterial wedge pressure (ß, 0.79; 95% CI, 0.32 to 1.26; P = 0.001), and decreased risk of PH (relative risk, 0.86; 95% CI, 0.74 to 0.99; P = 0.04) after multivariate adjustment. Vaspin levels were higher in patients without PH (median, 101.8 vs. 92.0 pg/ml; P < 0.001) but did not mediate the association between VAT and the risk of PH. SAT and BMI were not independently associated with risk of PH.

Conclusions:

Lower thoracic VAT was associated with a higher risk of PH in patients with advanced lung disease undergoing evaluation for lung transplantation. The role of adipokines in the pulmonary vascular disease remains to be evaluated.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Trasplante de Pulmón / Hipertensión Pulmonar Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Revista: Ann Am Thorac Soc Año: 2020 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Trasplante de Pulmón / Hipertensión Pulmonar Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Revista: Ann Am Thorac Soc Año: 2020 Tipo del documento: Article